Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway

Recent Patents on DNA and Gene Sequences

Volumn 3, Issue 3, 2009, Pages 177-182

  Cheung, Timothy C ^a  

^a CENTENARY INSTITUTE   (Australia)

Author keywords

BTLA; CD160; Coinhibition; Cosignaling; Costimulation; HVEM; Immune suppression; Immunotherapy; LIGHT; T cell proliferation; TNF superfamily; TNFSF14

Indexed keywords

B AND T LYMPHOCYTE ATTENUATOR; HERPESVIRUS ENTRY MEDIATOR; HERPESVIRUS ENTRY MEDIATOR LIGAND; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ANIMALS; CELL PROLIFERATION; HUMANS; PATENTS AS TOPIC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5; SIMPLEXVIRUS;

EID: 70449567241     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221509789318342     Document Type: Review

References (45)

1. Egen JG, Kuhns MS, Allison JP. CTLA-4: New insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002; 3: 611-618.
2. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002; 2: 116-126.
3. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23: 515-548.
4. Watanabe N, Gavrieli M, Sedy JR, et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 2003; 4: 670-679. (Pubitemid 36874444)
5. Han P, Goularte OD, Rufner K, et al. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J Immunol 2004; 172: 5931-5939. (Pubitemid 38621192)
6. Granger SW, Ware CF. Commentary: Turning on LIGHT. J Clin Invest 2001; 108: 1741-1742.
7. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001; 104: 487-501. (Pubitemid 32201945)
8. Croft M. Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? Nat Rev Immunol 2003; 3: 609-620.
9. Croft M. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev 2003; 14: 265-273. (Pubitemid 36693146)
10. Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005; 23: 23-68. (Pubitemid 40563164)
11. Vonderheide RH, June CH. A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapy. Immunol Res 2003; 27: 341-356.
12. Appleman LJ, Boussiotis VA. T cell anergy and costimulation. Immunol Rev 2003; 192: 161-180.
13. Saito T, Yamasaki S. Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors. Immunol Rev 2003; 192: 143-160. (Pubitemid 36613330)
14. Riley JL, June CH. The CD28 family: A T-cell rheostat for therapeutic control of T-cell activation. Blood 2005; 105: 13-21.
15. Subudhi SK, Alegre ML, Fu YX. The balance of immune responses: costimulation verse coinhibition. J Mol Med 2005; 83: 193-202.
16. Tamada K, Shimozaki K, Chapoval AI, et al. LIGHT, A TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 2000; 164: 4105-4110. (Pubitemid 30215066)
17. Kwon BS, Tan KB, Ni J, et al. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 1997; 272: 14272-14276. (Pubitemid 27232840)
18. Harrop JA, Reddy M, Dede K, et al. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J Immunol 1998; 161: 1786-1794. (Pubitemid 28387598)
19. Ye Q, Fraser CC, Gao W, et al. Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival J Exp Med 2002; 195: 795-800.
20. Scheu S, Alferink J, Potzel T, et al. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J Exp Med 2002; 195: 1613-1624. (Pubitemid 34666074)
21. Wan X, Zhang J, Luo H, et al A TNF family member LIGHT transduces costimulatory signals into human T cells. J Immunol 2002; 169: 6813-6821. (Pubitemid 36899266)
22. Mauri DN, Ebner R, Montgomery RI, et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998; 8: 21-30. (Pubitemid 28097820)
23. Montgomery RI, Warner MS, Lum B, et al. Herpes simplex virus 1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996; 87: 427-436. (Pubitemid 26374317)
24. Schneider K, Potter KG, Ware CF. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 2004; 202: 49-66. (Pubitemid 39576904)
25. Ware CF. NETWORK COMMUNICATIONS: Lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 2005; 23: 787-819.
26. Cheung TC, Humphreys IR, Potter KG, et al. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci USA 2005; 102: 13218-13223.
27. Cheung TC, Steinberg MW, Oborne LM, et al. Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc Natl Acad Sci USA 2009; 106: 6244-6249.
28. Compaan DM, Gonzalez LC, Tom I, et al. Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J Biol Chem 2005; 280: 39553-39561. (Pubitemid 41713914)
29. Sedy JR, Gavrieli M, Potter KG, et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 2005; 6: 90-98. (Pubitemid 40136700)
30. Cohavy O, Zhou J, Ware CF, et al. LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling. J Immunol 2005; 174: 646-653. (Pubitemid 40094256)
31. Gavrieli M, Watanabe N, Loftin SK, et al. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem Biophys Res Commun 2003; 312: 1236-1243. (Pubitemid 37490949)
32. Chemnitz JM, Lanfranco AR, Braunstein I, et al. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs. J Immunol 2006; 176: 6603-6614. (Pubitemid 43787843)
33. Gavrieli M, Murphy KM. Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA. Biochem Biophys Res Commun 2006; 345: 1440-1445. (Pubitemid 43817892)
34. Otsuki N, Kamimura Y, Hashiguchi M, et al. Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. Biochem Biophys Res Commun 2006; 344: 1121-1127.
35. Deppong C, Juehne TI, Hurchla M, et al. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J Immunol 2006; 176: 3909-3913. (Pubitemid 44264367)
36. Gonzalez LC, Loyet KM, Calemine-Fenaux J, et al. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc Natl Acad Sci USA 2005; 102: 1116-1121. (Pubitemid 40170735)
37. Cai G, Anumanthan A, Brown JA, et al. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 2008; 9: 176-185.
38. Murphy, K.M., Murphy, T.L., Sedy, J.R., Hurchla, M.A.: WO2007001459 (2007).
39. Korman, A., Selby, M., Thuduim, K. B., Halk, E., Srinivasan, M., More, D.B.: WO2008076560 (2008).
40. Granger, S.W., Shinichiro, K., Ware, C.F.: WO2006063067 (2006).
41. Chen, L., Koji, T.: US20080187542 (2008).
42. Banks TA, Rickert S, Ware CF. Restoring Immune Defenses via Lymphotoxin Signaling: Lessons from Cytomegalovirus. Immunol Res 2006; 34: 243-254. (Pubitemid 44195939)
43. Benedict CA, Banks TA, Senderowicz L, et al. Lymphotoxins and cytomegalovirus cooperatively induce interferon-b, establishing host-virus détente. Immunity 2001; 15: 617-626. (Pubitemid 33016446)
44. Yu P, Lee Y, Liu W, et al. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 2004; 5: 141-149. (Pubitemid 38208355)
45. Cheung, T.C., Humphrey, I.R., Potter, K.G., Benedict, C.A., Ware, C.F., De Trez, C., Croft, M., Kronenberg, M.: WO2006063067 (2006).